A detailed history of Bank Of Stockton transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Of Stockton holds 7,652 shares of NVO stock, worth $668,555. This represents 0.28% of its overall portfolio holdings.

Number of Shares
7,652
Previous 6,232 22.79%
Holding current value
$668,555
Previous $889,000 2.47%
% of portfolio
0.28%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$119.07 - $145.42 $169,079 - $206,496
1,420 Added 22.79%
7,652 $911,000
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $281,251 - $336,717
2,292 Added 58.17%
6,232 $889,000
Q1 2024

Apr 22, 2024

BUY
$102.11 - $135.92 $73,314 - $97,590
718 Added 22.28%
3,940 $505,000
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $282,827 - $339,759
3,222 New
3,222 $333,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bank Of Stockton Portfolio

Follow Bank Of Stockton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Stockton, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Stockton with notifications on news.